抄録
It has been revealed that various therapeutic agents for lifestyle-related diseases could affect bone metabolism. For example, thiazolidines, loop diuretics and warfarin would be possibly disadvantageous to bone metabolism. In many cases with lifestyle-related disease, it is necessary to take the medicine over a long term. Therefore, we should pay enough attention to bone metabolism during the selection of medicine, especially in the treatment of a high risk group for bone fracture. However, a majority of these drugs lack the evidence with randomized controlled trials for osteoporotic fracture. Further clinical research should be required to clarify the impact of each drug on osteoporosis with lifestyle-related diseases.
| 元の言語 | English |
|---|---|
| ページ（範囲） | 1661-1669 |
| ページ数 | 9 |
| ジャーナル | Clinical calcium |
| 巻 | 24 |
| 発行部数 | 11 |
| 出版物ステータス | Published - 01-11-2014 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
これを引用
}
Updates on Lifestyle-Related Diseases and Bone Metabolism. Effects of therapeutic agents for lifestyle-related diseases on osteoporosis. / Hayakawa, Nobuki; Suzuki, Atsushi.
：: Clinical calcium, 巻 24, 番号 11, 01.11.2014, p. 1661-1669.研究成果: Article
TY - JOUR
T1 - Updates on Lifestyle-Related Diseases and Bone Metabolism. Effects of therapeutic agents for lifestyle-related diseases on osteoporosis
AU - Hayakawa, Nobuki
AU - Suzuki, Atsushi
PY - 2014/11/1
Y1 - 2014/11/1
N2 - It has been revealed that various therapeutic agents for lifestyle-related diseases could affect bone metabolism. For example, thiazolidines, loop diuretics and warfarin would be possibly disadvantageous to bone metabolism. In many cases with lifestyle-related disease, it is necessary to take the medicine over a long term. Therefore, we should pay enough attention to bone metabolism during the selection of medicine, especially in the treatment of a high risk group for bone fracture. However, a majority of these drugs lack the evidence with randomized controlled trials for osteoporotic fracture. Further clinical research should be required to clarify the impact of each drug on osteoporosis with lifestyle-related diseases.
AB - It has been revealed that various therapeutic agents for lifestyle-related diseases could affect bone metabolism. For example, thiazolidines, loop diuretics and warfarin would be possibly disadvantageous to bone metabolism. In many cases with lifestyle-related disease, it is necessary to take the medicine over a long term. Therefore, we should pay enough attention to bone metabolism during the selection of medicine, especially in the treatment of a high risk group for bone fracture. However, a majority of these drugs lack the evidence with randomized controlled trials for osteoporotic fracture. Further clinical research should be required to clarify the impact of each drug on osteoporosis with lifestyle-related diseases.
UR - http://www.scopus.com/inward/record.url?scp=85016506987&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016506987&partnerID=8YFLogxK
M3 - Article
C2 - 25355150
AN - SCOPUS:85016506987
VL - 24
SP - 1661
EP - 1669
JO - Clinical calcium
JF - Clinical calcium
SN - 0917-5857
IS - 11
ER -